Annual Operating Profit
-$75.07 M
+$3.87 M+4.90%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual operaing income is currently -$75.07 million, with the most recent change of +$3.87 million (+4.90%) on 31 December 2023. During the last 3 years, it has fallen by -$37.78 million (-101.31%). EYPT annual operating profit is now -925.73% below its all-time high of $9.09 million, reached on 30 June 2010.EYPT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$32.75 M
+$1.80 M+5.20%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly operating income is currently -$32.75 million, with the most recent change of +$1.80 million (+5.20%) on 30 September 2024. Over the past year, it has dropped by -$18.35 million (-127.45%). EYPT quarterly operating profit is now -257.53% below its all-time high of $20.79 million, reached on 30 September 2014.EYPT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$116.97 M
-$18.35 M-18.61%
30 September 2024
Summary:
EyePoint Pharmaceuticals TTM operating income is currently -$116.97 million, with the most recent change of -$18.35 million (-18.61%) on 30 September 2024. Over the past year, it has dropped by -$35.22 million (-43.08%). EYPT TTM operating profit is now -1169.28% below its all-time high of $10.94 million, reached on 30 September 2014.EYPT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.9% | -127.5% | -43.1% |
| 3 y3 years | -101.3% | -113.9% | -134.1% |
| 5 y5 years | -205.7% | -132.9% | -200.9% |
EYPT Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -101.3% | +4.9% | -127.5% | +5.2% | -134.1% | at low |
| 5 y | 5 years | -205.7% | +4.9% | -1573.4% | +5.2% | -248.8% | at low |
| alltime | all time | -925.7% | +4.9% | -257.5% | +12.3% | -1169.3% | at low |
EyePoint Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$32.75 M(-5.2%) | -$116.97 M(+18.6%) |
| June 2024 | - | -$34.55 M(+3.7%) | -$98.62 M(+13.6%) |
| Mar 2024 | - | -$33.32 M(+103.7%) | -$86.83 M(+15.7%) |
| Dec 2023 | -$75.07 M(-4.9%) | -$16.35 M(+13.6%) | -$75.07 M(-8.2%) |
| Sept 2023 | - | -$14.40 M(-36.7%) | -$81.75 M(-4.7%) |
| June 2023 | - | -$22.76 M(+5.6%) | -$85.75 M(+4.3%) |
| Mar 2023 | - | -$21.55 M(-6.4%) | -$82.20 M(+4.1%) |
| Dec 2022 | -$78.94 M(+42.8%) | -$23.04 M(+25.2%) | -$78.93 M(+6.7%) |
| Sept 2022 | - | -$18.40 M(-4.3%) | -$73.95 M(+4.4%) |
| June 2022 | - | -$19.22 M(+5.1%) | -$70.86 M(+13.2%) |
| Mar 2022 | - | -$18.28 M(+1.3%) | -$62.63 M(+13.3%) |
| Dec 2021 | -$55.28 M(+48.2%) | -$18.05 M(+17.9%) | -$55.28 M(+10.6%) |
| Sept 2021 | - | -$15.31 M(+39.5%) | -$49.96 M(+36.5%) |
| June 2021 | - | -$10.98 M(+0.4%) | -$36.61 M(-0.5%) |
| Mar 2021 | - | -$10.94 M(-14.1%) | -$36.78 M(-1.4%) |
| Dec 2020 | -$37.29 M(-22.1%) | -$12.74 M(+550.8%) | -$37.29 M(+11.2%) |
| Sept 2020 | - | -$1.96 M(-82.5%) | -$33.54 M(-26.5%) |
| June 2020 | - | -$11.15 M(-2.6%) | -$45.64 M(+2.2%) |
| Mar 2020 | - | -$11.44 M(+27.4%) | -$44.65 M(-6.7%) |
| Dec 2019 | -$47.86 M(+94.9%) | -$8.98 M(-36.1%) | -$47.86 M(+23.1%) |
| Sept 2019 | - | -$14.06 M(+38.3%) | -$38.88 M(+1.3%) |
| June 2019 | - | -$10.16 M(-30.6%) | -$38.37 M(+1.0%) |
| Mar 2019 | - | -$14.65 M(+8.1%) | -$37.99 M(+12.3%) |
| Dec 2018 | -$24.56 M(-6.5%) | - | - |
| Sept 2018 | - | -$13.55 M(+38.6%) | -$33.82 M(+28.7%) |
| June 2018 | -$26.27 M(+41.4%) | -$9.78 M(+109.1%) | -$26.27 M(+16.1%) |
| Mar 2018 | - | -$4.68 M(-19.5%) | -$22.63 M(-2.1%) |
| Dec 2017 | - | -$5.81 M(-3.3%) | -$23.11 M(+32.8%) |
| Sept 2017 | - | -$6.01 M(-2.1%) | -$17.40 M(-6.4%) |
| June 2017 | -$18.58 M(-14.7%) | -$6.14 M(+18.9%) | -$18.58 M(-1.7%) |
| Mar 2017 | - | -$5.16 M(+5389.4%) | -$18.90 M(+0.3%) |
| Dec 2016 | - | -$94.00 K(-98.7%) | -$18.83 M(-21.5%) |
| Sept 2016 | - | -$7.19 M(+11.3%) | -$23.98 M(+10.1%) |
| June 2016 | -$21.77 M(-439.1%) | -$6.46 M(+26.7%) | -$21.77 M(+6.1%) |
| Mar 2016 | - | -$5.10 M(-2.7%) | -$20.52 M(+0.2%) |
| Dec 2015 | - | -$5.24 M(+5.1%) | -$20.47 M(+5.8%) |
| Sept 2015 | - | -$4.98 M(-4.2%) | -$19.35 M(-401.4%) |
| June 2015 | $6.42 M(-147.3%) | -$5.20 M(+2.9%) | $6.42 M(-15.6%) |
| Mar 2015 | - | -$5.05 M(+22.7%) | $7.61 M(-27.1%) |
| Dec 2014 | - | -$4.12 M(-119.8%) | $10.44 M(-4.6%) |
| Sept 2014 | - | $20.79 M(-617.9%) | $10.94 M(-180.6%) |
| June 2014 | -$13.57 M(+12.8%) | -$4.01 M(+80.6%) | -$13.57 M(+0.2%) |
| Mar 2014 | - | -$2.22 M(-38.5%) | -$13.54 M(-4.2%) |
| Dec 2013 | - | -$3.61 M(-2.8%) | -$14.12 M(+7.3%) |
| Sept 2013 | - | -$3.72 M(-6.6%) | -$13.16 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | -$12.03 M(+15.9%) | -$3.98 M(+41.6%) | -$12.03 M(+16.1%) |
| Mar 2013 | - | -$2.81 M(+6.2%) | -$10.36 M(+0.8%) |
| Dec 2012 | - | -$2.65 M(+2.2%) | -$10.28 M(-1.6%) |
| Sept 2012 | - | -$2.59 M(+12.1%) | -$10.44 M(+0.6%) |
| June 2012 | -$10.38 M(+3.8%) | -$2.31 M(-15.3%) | -$10.38 M(+23.9%) |
| Mar 2012 | - | -$2.73 M(-3.1%) | -$8.38 M(-4.7%) |
| Dec 2011 | - | -$2.81 M(+11.1%) | -$8.79 M(-3.4%) |
| Sept 2011 | - | -$2.53 M(+721.8%) | -$9.10 M(-9.0%) |
| June 2011 | -$10.00 M(-210.0%) | -$308.00 K(-90.2%) | -$10.00 M(-503.5%) |
| Mar 2011 | - | -$3.14 M(+0.6%) | $2.48 M(-10.0%) |
| Dec 2010 | - | -$3.12 M(-9.1%) | $2.75 M(-52.2%) |
| Sept 2010 | - | -$3.44 M(-128.2%) | $5.76 M(-36.6%) |
| June 2010 | $9.09 M(-296.1%) | $12.17 M(-525.2%) | $9.09 M(-389.7%) |
| Mar 2010 | - | -$2.86 M(+2433.6%) | -$3.14 M(+197.2%) |
| Dec 2009 | - | -$113.00 K(+5.6%) | -$1.06 M(-55.3%) |
| Sept 2009 | - | -$107.00 K(+94.5%) | -$2.36 M(-49.0%) |
| June 2009 | -$4.64 M(-81.4%) | -$55.00 K(-93.0%) | -$4.64 M(-51.8%) |
| Mar 2009 | - | -$781.00 K(-45.0%) | -$9.62 M(-37.7%) |
| Dec 2008 | - | -$1.42 M(-40.3%) | -$15.45 M(-30.0%) |
| Sept 2008 | - | -$2.38 M(-52.8%) | -$22.07 M(-11.4%) |
| June 2008 | -$24.90 M(-29.9%) | -$5.04 M(-23.7%) | -$24.90 M(-56.5%) |
| Mar 2008 | - | -$6.61 M(-17.8%) | -$57.18 M(+13.2%) |
| Dec 2007 | - | -$8.04 M(+54.2%) | -$50.51 M(-0.9%) |
| Sept 2007 | - | -$5.21 M(-86.0%) | -$50.97 M(+13.4%) |
| June 2007 | -$35.54 M(+28.4%) | -$37.32 M(<-9900.0%) | -$44.97 M(+23.6%) |
| Mar 2007 | - | $65.00 K(-100.8%) | -$36.38 M(+0.8%) |
| Dec 2006 | - | -$8.50 M(-1175.4%) | -$36.09 M(+34.1%) |
| Sept 2006 | - | $790.40 K(-102.8%) | -$26.92 M(-1.5%) |
| June 2006 | -$27.68 M(+90.2%) | -$28.73 M(-8264.7%) | -$27.33 M(+100.5%) |
| Mar 2006 | - | $351.90 K(-47.5%) | -$13.63 M(-1.4%) |
| Dec 2005 | - | $670.70 K(+78.8%) | -$13.82 M(-3.6%) |
| Sept 2005 | - | $375.10 K(-102.5%) | -$14.33 M(-1.5%) |
| June 2005 | -$14.55 M(+133.3%) | -$15.03 M(-9470.5%) | -$14.56 M(+143.3%) |
| Mar 2005 | - | $160.40 K(-0.9%) | -$5.98 M(-1.4%) |
| Dec 2004 | - | $161.80 K(+7.4%) | -$6.07 M(-1.5%) |
| Sept 2004 | - | $150.70 K(-102.3%) | -$6.16 M(-1.4%) |
| June 2004 | -$6.24 M(+73.4%) | -$6.46 M(-8954.7%) | -$6.25 M(+81.7%) |
| Mar 2004 | - | $72.90 K(+1.5%) | -$3.44 M(-1.6%) |
| Dec 2003 | - | $71.80 K(+10.6%) | -$3.49 M(-1.6%) |
| Sept 2003 | - | $64.90 K(-101.8%) | -$3.55 M(-1.4%) |
| June 2003 | -$3.60 M(+181.3%) | -$3.65 M(<-9900.0%) | -$3.60 M(-7728.4%) |
| Mar 2003 | - | $16.70 K(+7.7%) | $47.20 K(+54.8%) |
| Dec 2002 | - | $15.50 K(+3.3%) | $30.50 K(+103.3%) |
| Sept 2002 | - | $15.00 K | $15.00 K |
| June 2002 | -$1.28 M(+194.2%) | - | - |
| June 2001 | -$434.60 K | - | - |
FAQ
- What is EyePoint Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual operating profit year-on-year change?
- What is EyePoint Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly operating profit year-on-year change?
- What is EyePoint Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals TTM operating profit year-on-year change?
What is EyePoint Pharmaceuticals annual operaing income?
The current annual operating profit of EYPT is -$75.07 M
What is the all time high annual operating profit for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual operaing income is $9.09 M
What is EyePoint Pharmaceuticals annual operating profit year-on-year change?
Over the past year, EYPT annual operaing income has changed by +$3.87 M (+4.90%)
What is EyePoint Pharmaceuticals quarterly operating income?
The current quarterly operating profit of EYPT is -$32.75 M
What is the all time high quarterly operating profit for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly operating income is $20.79 M
What is EyePoint Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, EYPT quarterly operating income has changed by -$18.35 M (-127.45%)
What is EyePoint Pharmaceuticals TTM operating income?
The current TTM operating profit of EYPT is -$116.97 M
What is the all time high TTM operating profit for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high TTM operating income is $10.94 M
What is EyePoint Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, EYPT TTM operating income has changed by -$35.22 M (-43.08%)